Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

MC De Rijk, LJ Launer, K Berger, MM Breteler… - Neurology, 2000 - europepmc.org
The results of seven population-based studies were examined separately and pooled to
obtain age-and sex-specific estimates of the prevalence of PD. An in-person screening …

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the …

MC De Rijk, C Tzourio, MM Breteler… - Journal of Neurology …, 1997 - jnnp.bmj.com
OBJECTIVES: To assess and compare the prevalence of parkinsonism and Parkinson's
disease in five European populations that were surveyed with similar methodology and …

Prevalence of Parkinson's disease in the elderly: the Rotterdam Study

MC De Rijk, MMB Breteler, GA Graveland, A Ott… - Neurology, 1995 - AAN Enterprises
We assessed the prevalence of Parkinson's disease (PD) in a general elderly population in
the Netherlands. The study formed part of the Rotterdam Study, a population-based door-to …

Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study

LML De Lau, P Giesbergen, MC De Rijk, A Hofman… - Neurology, 2004 - AAN Enterprises
Objective: To investigate the incidence of parkinsonism and Parkinson disease (PD) in the
general population using in-person screening along with clinical data. Methods: In the …

Dietary antioxidants and Parkinson disease: the Rotterdam Study

MC de Rijk, MMB Breteler, JH den Breeijen… - Archives of …, 1997 - jamanetwork.com
Objective: To investigate whether high dietary intake of antioxidants decreases the risk of
Parkinson disease (PD). Setting: The community-based Rotterdam Study, the Netherlands …

A population perspective on diagnostic criteria for Parkinson's disease

MC De Rijk, WA Rocca, DW Anderson, MO Melcon… - Neurology, 1997 - AAN Enterprises
For Parkinson's disease (PD), little is known about how the choice of diagnostic criteria
affects research results. Using data on PD from three community studies (from Argentina, the …

Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study

MM van der Graaff, CA Sage, MWA Caan… - Brain, 2011 - academic.oup.com
Motoneuron disease is a term encompassing three phenotypes defined largely by the
balance of upper versus lower motoneuron involvement, namely amyotrophic lateral …

APOE and the risk of PD with or without dementia in a population-based study

BS Harhangi, MC De Rijk, CM Van Duijn… - Neurology, 2000 - AAN Enterprises
Objective: To study the association between APOE genotype and PD with or without
dementia. Methods: The study formed part of the Rotterdam Study, a prospective, population …

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled …

C Walgaard, BC Jacobs, HF Lingsma… - The Lancet …, 2021 - thelancet.com
Background Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is
insufficient in a proportion of patients with severe Guillain-Barré syndrome. Worldwide …

Second IVIg Course in Guillain‐Barré Syndrome patients with poor prognosis (SID‐GBS trial): protocol for a double‐blind randomized, placebo‐controlled clinical trial

C Walgaard, BC Jacobs, HF Lingsma… - Journal of the …, 2018 - Wiley Online Library
One course of intravenous immunoglobulins (IVIg) of 2 g/kg is standard treatment in Guillain‐
Barré syndrome (GBS) patients unable to walk independently. Despite treatment some …